Results 131 to 140 of about 1,518 (207)

Open-label treatment extension of ruxolitinib cream in vitiligo: findings from the Topical Ruxolitinib Evaluation in Vitiligo (TRuE-V) long-term extension phase III study [PDF]

open access: hybrid
John E. Harris   +14 more
openalex   +1 more source

Hidden in PlAIN Sight [PDF]

open access: yes, 2023
Aslam, Saher, et. al.
core   +2 more sources

Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies. [PDF]

open access: yesAm J Clin Dermatol, 2023
Bloudek L   +8 more
europepmc   +1 more source

Jak inhibitors in the treatment of alopecia areata - a literature review [PDF]

open access: yes
Introduction Alopecia areata (AA) is a chronic autoimmune disorder causing non-scarring hair loss, which can range from isolated patches to complete scalp (alopecia totalis, AT) or body hair loss (alopecia universalis, AU). It affects people of all ages,
Krochmal, Karolina   +9 more
core   +1 more source

Efficacy and safety of ruxolitinib cream combined with narrow-band UVB phototherapy for treatment of vitiligo

open access: hybrid
Amit G. Pandya   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy